Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction
Status:
Recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
In this study ASA 1, 2 individuals with grade 1 or 2 diastolic dysfunction will be recruited
to assess the effects of Remifentanil infusion on left ventricular function evaluated with
transthoracic echocardiagraphy.